# Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

> **NCT05358535** · PHASE3 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Anesthesia
- Propofol Adverse Reaction
- Etomidate Adverse Reaction
- Anesthesia Complication
- Anesthesia; Adverse Effect
- Anesthesia; Reaction

## Interventions

- **DRUG:** Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)
- **DRUG:** Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)

## Key facts

- **NCT ID:** NCT05358535
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-19
- **Primary completion:** 2027-01
- **Final completion:** 2027-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358535, "Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05358535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*